Jennifer Chu, M.D., is CEO and Principal of eToims® Soft Tissue
Comfort Center
and eToims® Medical Technology LLC, (eToims® medical device manufacturing
company). She is an Emeritus Associate Professor in the Department of Physical
Medicine and Rehabilitation at the University
of Pennsylvania, where
she has been on faculty for over 30 years. The present state-of-the-art
eToims®, is a continuation of the trajectory that began in 1990 and evolved
from the fusion of medical acupuncture, electromyography & nerve conduction
diagnostics, and applied anatomy & neurophysiology.
She authored many peer-reviewed publications including a textbook entitled
"Electrodiagnosis: An Anatomical and Clinical Approach.” Not only is she
an active member of numerous prestigious national medical societies, she was
awarded honorary membership in the European Society of Physical Medicine and
Rehabilitation. She holds four issued patents, plus three pending patents, for
the purpose of providing soft tissue comfort. Her initial patents involved
various needling devices for mechanical and electrical elicitation of twitches
at trigger points. The pending patents involve the revolutionary noninvasive
eToims® which has helped many patients to significantly improve their quality
of life since 2005.
Jennifer Chu, M.D. is involved in various medical and professional
organizations. She is also the President of the Alumni Myanmar Institutes of
Medicine Association, a nonprofit organization to alleviate poverty in Myanmar.
Her patients funded Pain-free International Charitable Foundation, a nonprofit
organization to promote knowledge of eToims® in myofascial pain and
fibromyalgia management. She retired from the University
of Pennsylvania in 2006 and continues
to teach residents in Physical Medicine and Rehabilitation at the Hospital of
the University of
Pennsylvania on topics of
electrodiagnostic and neuromuscular medicine.
Dr. Jennifer Chu's Profile
Associate Professor, Department of Rehabilitation Medicine, School of Medicine
of the University
of Pennsylvania.
Director: Electrodiagnostic
Medicine(1977-206); Penn
Soft Tissue
Comfort Center
(2004-2006)
Board Certification: Physical Medicine and
Rehabilitation (1979).
Active fellowships: American Association of
Neuromuscular and Electrodiagnostic Medicine (1980); American Academy of Pain Management
(1991)
Residency: Physical Medicine and
Rehabilitation, Hospital of the University
of Pennsylvania (1977)
Post Graduate Training: Electrodiagnostic
Medicine, University of Uppsala,
Sweden (1982)
Educational Background: MD, Institute of Medicine2,
Yangon, Myanmar (1971)
Special Interests: Automated and electrical
twitch-obtaining intramuscular stimulation, electrodiagnostic medicine,
quantitative electromyography, soft tissue, myofascial pain syndrome and
fibromyalgia pain, acute and chronic refractory neuropathic pain, medico-legal
diagnostic and treatment aspects of soft tissue, myofascial and fibromyalgia
pain.
Honors and awards: Honorary member of (1)
European Society of Physical Medicine and Rehabilitation (2) Belgian Society of
Physical Medicine and Rehabilitation.
eToims® News:
August 2008: eToims® Medical Technology, LLC forms its Scientific Advisory
Board consisting of a distinguished group of national and international
physicians. eToims® is expected to receive European regulatory clearance within
the next 1-2 months and 510(k) FDA approval thereafter. There are more than 100,000
potential eToims practitioners in the U.S. alone, including physical
therapists, rehabilitation medicine physicians, chiropractors, and other pain
clinicians.
August 2008: eToims® Medical Technology, LLC is selected to present at the
AdvaMed Advanced Medical Technology Conference in Washington, DC
in September 2008 (
http://www.advamed2008.com/">http://www.advamed2008.com/).
AdvaMed is the industry's largest association. Advamed member companies
produce 90% of the U.S.
health care technology industry's $75 billion annual purchase power.
August 2008: Study published in the August 2008 issue of the Journal
of Electromyography and Clinical Neurophysiology on the safety and
efficacy of eToims® Twitch Relief Method and ET 127 device used in management
of nearly 100 patients with chronic refractory myofascial pain.
May 2008: eToims® Medical Technology, LLC receives recognition as one of the
top 3 Emerging Growth Biotechnology Companies of 2008 from Benjamin Franklin
Technology Partners of Pennsylvania and Entrepreneurs Forum of Greater
Philadelphia (
http://www.benfranklinawards.org/index2008.swf">http://www.benfranklinawards.org/index2008.swf).
It is our mission to
develop and implement leading neuromuscular pain solutions for
individuals suffering from acute and chronic nerve-related muscle pain.
We are committed to developing efficacious treatments and advanced
technologies of the highest caliber, and believe that it is our social
responsibility to spread our neuromuscular pain advancements to
individuals suffering from nerve related pain around the world. We
believe that fulfilling our mission will result in health improvement
for our customers, in addition to growth for our partners, suppliers,
and shareholders.
eToims® Medical Technology, LLC
is a private health care technology firm focused on providing advanced
neuromuscular pain rehabilitation through the application of
proprietary and patented Electrical Twitch Obtaining Intramuscular
Stimulation (eToims®).
The company, founded in
mid-2006, developed non-invasive eToims® following a trajectory of
eToims®-related neuromuscular pain research that began in 1990 by
Jennifer Chu, M.D. at the Department of Physical Medicine and
Rehabilitation, University of Pennsylvania.
Dr. Chu
holds the position of CEO and is responsible for guiding the strategic
vision for eToims®, while Dr. Chu's son, Justin Andrews, a former
investment analyst at NY-based global hedge fund Indus Capital
Partners, serves as Managing Director. Mr. Andrews was previously
responsible for more than US$300 million of health care and consumer
investments in Asia, Japan, and Europe and authored the eToims®
business plan in 2003 while a sophomore at the University of Southern
California.
eToims® Medical Technology, LLC is fully
funded by the Chu family, which left political turmoil in Rangoon,
Burma during the mid-1970s. Dr. Chu's connection with the University
of Pennsylvania stemmed from her physician father's association with
UPenn's renowned Chairman of Surgery Isidore S. Ravdin, M.D., during
World War II while Ravdin was at the 20th General Hospital in the
China-Burma-India (CBI) Theater.
eToims® Soft Tissue Comfort Center, LLC is engaged in spreading the
eToims® treatment and technology developed by eToims® Medical
Technology, LLC through partnerships with physical therapy and other
pain care centers around the world. Joint ventures with physical
therapy outfits are typically located in Fitness Centers, Health Spas,
and other entities that have sizable populations of cash-paying
customers with neuromuscular pain-related issues. eToims® Massages are
superior to traditional massages and other forms of pain care as
eToims® is able to painlessly mobilize deep tissues from within, while
traditional massage effects only reach surface muscles.